@article{article_789537, title={MOLECULAR DOCKING STUDIES ON SOME BENZAMIDE DERIVATIVES AS TOPOISOMERASE INHIBITORS}, journal={Journal of Faculty of Pharmacy of Ankara University}, volume={44}, pages={470–480}, year={2020}, DOI={10.33483/jfpau.789537}, author={Yilmaz, Serap and Ataei, Sanaz and Yıldız, İlkay}, keywords={Antikanser, Benzamid, Doking, Topoizomeraz I, Topoizomeraz IIα}, abstract={<div style="text-align:justify;"> <span style="font-size:12px;"> <b>Objective: </b>In order to examine the interactions of some benzamide derivatives, which are thought to exhibit anti-cancer activity, with human Topo I and IIα enzymes at the molecular level, docking studies were carried out on these enzymes. </span> </div> <div style="text-align:justify;"> <span style="font-size:12px;"> <b>Material and Method: </b>In conducting the docking studies, the protein was selected from the protein data bank for Topo I (1K4T) and for Topo IIα (5GWK). Doking was performed with the CDocker method using the Discovery studio 3.5 program, and the binding energies of benzamide derivatives to enzymes were calculated and their molecular interactions were revealed. </span> </div> <div style="text-align:justify;"> <span style="font-size:12px;"> <b>Result and Discussion: </b> As a result of the docking process on Topo I and IIα, it was found that benzamide derivative compounds have higher affinity for Topo IIα enzyme. For Topo I compounds 4N6, 5N5; for Topo IIa compounds 5N3, 5N7 have been identified as promising compounds in terms of anticancer activity. </span> </div>}, number={3}, publisher={Ankara Üniversitesi}